We are live on ! Find out more
AIM

Anchor Investment Management Portfolio holdings

AUM $1.2B
1-Year Est. Return 17.33%
This Fund
S&P 500
This Quarter Est. Return
+2.27%
1 Year Est. Return
+17.33%
3 Year Est. Return
+59.36%
5 Year Est. Return
+74.25%
10 Year Est. Return
+247.66%
AUM
$302M
AUM Growth
+$10.5M
Cap. Flow
+$5.6M
Cap. Flow %
1.86%
Top 10 Hldgs %
20.38%
Holding
720
New
21
Increased
161
Reduced
152
Closed
19

Top Sells

Rank Stock Value
1
APA icon
APA Corp
APA
+$354K
2
SLB icon
SLB Ltd
SLB
+$328K
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$319K
4
AXTA icon
Axalta
AXTA
+$245K
5
TSCO icon
Tractor Supply
TSCO
+$228K

Sector Composition

Rank Sector Weight
1 Healthcare 15.67%
2 Financials 14.42%
3 Industrials 11.71%
4 Technology 10.44%
5 Consumer Staples 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
51
Chevron
CVX
$371B
$1.71M 0.57%
16,429
-598
-4% -$63.4K
MO icon
52
Altria Group
MO
$113B
$1.68M 0.56%
22,517
+240
+1% +$17.6K
FISV
53
Fiserv Inc
FISV
$28.9B
$1.67M 0.55%
27,290
-1,220
-4% -$73.8K
CSCO icon
54
Cisco
CSCO
$476B
$1.63M 0.54%
52,028
-205
-0.4% -$6.68K
JPM icon
55
JPMorgan Chase
JPM
$947B
$1.59M 0.53%
17,441
-50
-0.3% -$4.31K
AXP icon
56
American Express
AXP
$231B
$1.58M 0.52%
18,742
-60
-0.3% -$4.75K
SNY icon
57
Sanofi
SNY
$103B
$1.52M 0.5%
31,722
+1,750
+6% +$83.6K
SLB icon
58
SLB Ltd
SLB
$76.5B
$1.52M 0.5%
23,079
-4,575
-17% -$328K
SYK icon
59
Stryker
SYK
$129B
$1.49M 0.5%
10,771
-100
-0.9% -$13.7K
TMO icon
60
Thermo Fisher Scientific
TMO
$214B
$1.45M 0.48%
8,320
-155
-2% -$26K
MDLZ icon
61
Mondelez International
MDLZ
$80.1B
$1.44M 0.48%
33,308
RSG icon
62
Republic Services
RSG
$64.5B
$1.42M 0.47%
22,345
ORCL icon
63
Oracle
ORCL
$413B
$1.37M 0.46%
27,363
-700
-2% -$31.9K
BNY
64
Bank of New York Mellon
BNY
$108B
$1.37M 0.45%
26,798
+1,167
+5% +$55.8K
IBM icon
65
IBM
IBM
$220B
$1.35M 0.45%
9,210
-288
-3% -$43.4K
CL icon
66
Colgate-Palmolive
CL
$74.1B
$1.33M 0.44%
17,888
-120
-0.7% -$8.91K
ADBE icon
67
Adobe
ADBE
$103B
$1.32M 0.44%
9,361
+178
+2% +$24.4K
ADP icon
68
Automatic Data Processing
ADP
$109B
$1.32M 0.44%
12,835
-350
-3% -$35.4K
SBUX icon
69
Starbucks
SBUX
$120B
$1.29M 0.43%
22,208
-760
-3% -$46K
LLY icon
70
Eli Lilly
LLY
$1.06T
$1.29M 0.43%
15,706
-200
-1% -$16.3K
BAX icon
71
Baxter International
BAX
$14B
$1.29M 0.43%
21,263
+1,050
+5% +$59.6K
WBA
72
DELISTED
Walgreens Boots Alliance
WBA
$1.28M 0.42%
16,337
+440
+3% +$36.2K
AMGN icon
73
Amgen
AMGN
$219B
$1.27M 0.42%
7,383
-30
-0.4% -$4.88K
AFL icon
74
Aflac
AFL
$64.5B
$1.23M 0.41%
31,654
-100
-0.3% -$3.76K
BIV icon
75
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$1.21M 0.4%
14,345
-1,525
-10% -$129K

Similar funds

Anchor Investment Management's Q2 2017 Portfolio in Review

As of Q2 2017, Anchor Investment Management held 720 positions worth $302M, up 3.6% from $291M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Anchor Investment Management's Q2 2017 filing shows 21 new, 161 increased, 152 reduced and 19 closed positions. Its largest new stake was Vanguard Global ex-US Real Estate ETF: 4,835 shares worth $272K. The largest sale was APA Corp, an estimated $354K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Anchor Investment Management's largest Q2 2017 buy was Vanguard Global ex-US Real Estate ETF: 4,835 shares worth $272K.
  • Anchor Investment Management added most to Vanguard Short-Term Corporate Bond ETF in Q2 2017, an estimated $982K increase.
  • Anchor Investment Management's biggest Q2 2017 reduction was APA Corp, cutting an estimated $354K.
  • Anchor Investment Management fully exited Axalta in Q2 2017, selling an estimated $245K.
  • Anchor Investment Management's ten largest holdings make up 20% of its $302M portfolio in Q2 2017.
  • Anchor Investment Management opened 21 new positions and closed 19 in Q2 2017.
  • Anchor Investment Management's portfolio value rose 3.6% quarter-over-quarter to $302M.

Based on Anchor Investment Management's 13F filing for Q2 2017, filed 3 Jan 2024.